Pembrolizumab-Induced Delayed-Onset Hepatitis

Hepatitis is one of the serious immune-related adverse events (irAEs). However, delayed-onset hepatitis induced by immune-checkpoint inhibitors (ICIs) is rare, and the histopathological features remain to be clarified. A 65-year-old woman with advanced lung adenocarcinoma in the right upper lobe (cT...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Case Rep Gastroenterol
Päätekijät: Kanaoka, Kensuke, Moriizumi, Kazunori, Okada, Hideyasu, Iwahashi, Kiyoshi, Tsuji, Hiromi, Yasuoka, Hironao, Minami, Seigo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: S. Karger AG 2020
Aiheet:
Single Case
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7670324/
https://ncbi.nlm.nih.gov/pubmed/33250701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000509953
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia